Page 35 - Colitis Foundation News Today

Crohn’s disease is one of two types of inflammatory bowel disease (IBD), the other being ulcerative colitis.

The rate of clinical remission was 47.9 percent in patients who received combination induction therapy with guselkumab and golimumab compared with either treatment alone at 38 weeks1 ... | October 10, 2022

For many people with chronic illnesses, access to public restrooms can be a critical medical issue. Incentivizing businesses to open their restrooms can fill a critical gap in U.S. cities.

This weekend, a St. Charles County man is putting his best foot forward for a good cause.

New research is the first to show a bi-directional link between inflammatory bowel disease and depression.

/PRNewswire/ -- A new study may have solved a mystery surrounding Crohns disease, an inflammatory bowel illness where immune defenses, meant to attack...

Lee Nightingale, co-owner of Poway Pilates, got the band back together

A new study may have solved a mystery surrounding Crohn's disease, a type of inflammatory bowel disease in which immune defenses meant to attack invading microbes instead mistakenly target the body's own digestive tract.

An analysis of 655 youth with inflammatory bowel disease (IBD) was conducted in order to further the therapeutic and research utility of the Transition Readiness Assessment Questionnaire (TRAQ-20).

Friends and family remembered the 25-year-old who died hiking Long's Peak.